Larimar Therapeutics, Inc. (LRMR)
3.32
-0.54
(-14.10%)
USD |
NASDAQ |
Sep 24, 16:00
3.32
0.00 (0.00%)
After-Hours: 19:59
Larimar Therapeutics Market Cap : 346.55M for Sept. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 24, 2026 | 346.55M |
| September 23, 2026 | 403.44M |
| September 22, 2026 | 398.74M |
| September 21, 2026 | 399.79M |
| September 18, 2026 | 395.61M |
| September 17, 2026 | 396.66M |
| September 16, 2026 | 410.22M |
| September 15, 2026 | 408.14M |
| September 14, 2026 | 394.57M |
| September 11, 2026 | 409.18M |
| September 10, 2026 | 401.87M |
| September 09, 2026 | 403.96M |
| September 08, 2026 | 425.36M |
| September 04, 2026 | 399.79M |
| September 03, 2026 | 399.79M |
| September 02, 2026 | 403.96M |
| September 01, 2026 | 411.27M |
| August 31, 2026 | 398.74M |
| August 28, 2026 | 418.58M |
| August 27, 2026 | 422.75M |
| August 26, 2026 | 435.28M |
| August 25, 2026 | 434.23M |
| August 24, 2026 | 422.75M |
| August 21, 2026 | 436.32M |
| August 20, 2026 | 434.23M |
| Date | Value |
|---|---|
| August 19, 2026 | 443.63M |
| August 18, 2026 | 423.79M |
| August 17, 2026 | 450.93M |
| August 14, 2026 | 455.11M |
| August 13, 2026 | 445.72M |
| August 12, 2026 | 456.15M |
| August 11, 2026 | 449.89M |
| August 10, 2026 | 418.58M |
| August 07, 2026 | 434.23M |
| August 06, 2026 | 438.41M |
| August 05, 2026 | 427.97M |
| August 04, 2026 | 429.01M |
| August 03, 2026 | 415.44M |
| July 31, 2026 | 398.74M |
| July 30, 2026 | 399.26M |
| July 29, 2026 | 378.91M |
| July 28, 2026 | 399.79M |
| July 27, 2026 | 399.79M |
| July 24, 2026 | 417.53M |
| July 23, 2026 | 418.58M |
| July 22, 2026 | 419.62M |
| July 21, 2026 | 410.22M |
| July 20, 2026 | 399.79M |
| July 17, 2026 | 386.22M |
| July 16, 2026 | 383.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.818B |
| Alnylam Pharmaceuticals, Inc. | 33.38B |
| Anika Therapeutics, Inc. | 270.74M |
| Savara, Inc. | 1.041B |
| Vericel Corp. | 2.011B |
Market Cap Related Metrics
| PEG Ratio | -0.062 |
| Price to Book Value | 2.721 |
| Price | 3.32 |
| Earnings Yield | -59.73% |
| PEGY Ratio | -0.062 |